Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
| Autor: | Choueiri, Toni K *, Albiges, Laurence, Barthélémy, Philippe, Iacovelli, Roberto, Emambux, Sheik, Molina-Cerrillo, Javier, Garmezy, Benjamin, Barata, Pedro, Basu, Arnab, Bourlon, Maria T, Moon, Helen, Ratta, Raffaele, McKay, Rana R, Chehrazi-Raffle, Alexander, Hammers, Hans, Heng, Daniel Y C, Braendle, Edgar, Beckermann, Kathryn E, McGregor, Bradley A, Motzer, Robert J |
|---|---|
| Zdroj: | In The Lancet 5-11 October 2024 404(10460):1309-1320 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|